Gomes M, Ferreira P, Almeida A, Cornelio J, Arruda T, Mafra A
BMC Cancer. 2025; 25(1):416.
PMID: 40055649
PMC: 11887319.
DOI: 10.1186/s12885-025-13695-y.
Xia Q, Pierson S
Int J Mol Sci. 2025; 26(4).
PMID: 40003891
PMC: 11855562.
DOI: 10.3390/ijms26041424.
Li X, Zhu Y, Wan H
Front Psychiatry. 2025; 15:1488196.
PMID: 39896992
PMC: 11782992.
DOI: 10.3389/fpsyt.2024.1488196.
Kwon H, Kim S, Jin S, Shin S, Lee J, Park M
Sci Rep. 2025; 15(1):3127.
PMID: 39856184
PMC: 11760350.
DOI: 10.1038/s41598-025-87195-1.
Hassan S, Alqahtani M
Cureus. 2025; 16(12):e75634.
PMID: 39803043
PMC: 11725335.
DOI: 10.7759/cureus.75634.
[Analysis of positioning errors in head and neck cancers during radiotherapy assisted by the 6D treatment couch and image-guided radiation therapy].
Tian S, Sun H, Zhao T, Wang W
Beijing Da Xue Xue Bao Yi Xue Ban. 2024; 56(6):1097-1100.
PMID: 39690776
PMC: 11652978.
Pregabalin for Neuropathic Pain in Post-radiotherapy Head and Neck Cancer Patients: A Retrospective Study and Review of the Literature.
Kouri M, Papadopoulou E, Vardas E, Georgaki M, Rekatsina M, Tsaroucha A
Cureus. 2024; 16(11):e72951.
PMID: 39640140
PMC: 11617120.
DOI: 10.7759/cureus.72951.
[Effects of Ionizing Radiation on Intestinal Bile Acid Metabolism: Mechanism of the Radioprotective Effect of Glycoursodeoxycholic Acid].
Dai J, Gao Y, Wang J, Zhang S, Liu P
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(5):1195-1201.
PMID: 39507959
PMC: 11536250.
DOI: 10.12182/20240960403.
Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma.
Korns J, Wicker C, Lehn M, Shyamsunder S, Thompson S, Lester C
Cancer Lett. 2024; 606:217320.
PMID: 39489210
PMC: 11583984.
DOI: 10.1016/j.canlet.2024.217320.
Cobaltabis(Dicarbollide) [-COSAN] for Boron Neutron Capture Therapy of Head and Neck Cancer: Biodistribution and Irradiation Studies in an Experimental Oral Cancer Model.
Palmieri M, Monti Hughes A, Trivillin V, Garabalino M, Ramos P, Thorp S
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459007
PMC: 11510372.
DOI: 10.3390/ph17101367.
Radioprotection Performance Evaluation of 3D-Printed and Conventional Heat-Cured Dental Resins for Radiotherapy Prostheses.
Wang J, Murase M, Sumita Y, Notake R, Akiyama M, Yoshimura R
J Funct Biomater. 2024; 15(10).
PMID: 39452581
PMC: 11508738.
DOI: 10.3390/jfb15100282.
Targeting ferroptosis for improved radiotherapy outcomes in HPV-negative head and neck squamous cell carcinoma.
Noh J, Lee M, Lee Y, Bae M, Min S, Kong M
Mol Oncol. 2024; 19(2):540-557.
PMID: 39297393
PMC: 11792990.
DOI: 10.1002/1878-0261.13720.
Radiation Dose-Induced Carotid Artery Stenosis and Brain Necrosis in Head and Neck Cancer-A Real World Cohort Study.
Leung H, Wang S, Lin C, Chan A
Cancers (Basel). 2024; 16(17).
PMID: 39272840
PMC: 11394158.
DOI: 10.3390/cancers16172982.
Head and neck cancer: pathogenesis and targeted therapy.
Liu Y, Zhang N, Wen Y, Wen J
MedComm (2020). 2024; 5(9):e702.
PMID: 39170944
PMC: 11338281.
DOI: 10.1002/mco2.702.
Proton Therapy in The Treatment of Head And Neck Cancers- Review.
Bala K, Samovich Y, Dorobisz K
Curr Oncol Rep. 2024; 26(11):1380-1387.
PMID: 39115677
PMC: 11579081.
DOI: 10.1007/s11912-024-01592-9.
Mapping the landscape: a bibliometric study of global chimeric antigen receptor T cell immunotherapy research.
Zhang W, Wei W, Ma L, Du H, Jin A, Luo J
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9227-9241.
PMID: 38953967
DOI: 10.1007/s00210-024-03258-6.
Does adaptive radiotherapy for head and neck cancer favorably impact dosimetric, clinical, and toxicity outcomes?: A review.
Simopoulou F, Kyrgias G, Georgakopoulos I, Avgousti R, Armpilia C, Skarlos P
Medicine (Baltimore). 2024; 103(26):e38529.
PMID: 38941415
PMC: 11466102.
DOI: 10.1097/MD.0000000000038529.
A Survey of Manual Therapy Techniques and Protocols Used to Prevent or Treat Dysphagia in Head and Neck Cancer Patients During and after Radiation Therapy.
Daniels K, Chanda A, Berry L, Edke A, Patel P, Wun A
Glob Adv Integr Med Health. 2024; 13:27536130241263349.
PMID: 38903482
PMC: 11189010.
DOI: 10.1177/27536130241263349.
.
Shams S
Can Oncol Nurs J. 2024; 34(2):232-237.
PMID: 38706656
PMC: 11068338.
DOI: 10.5737/23688076342232.
.
Shams S
Can Oncol Nurs J. 2024; 34(2):238-244.
PMID: 38706647
PMC: 11068339.
DOI: 10.5737/23688076342238.